Halozyme Therapeutics (HALO)
Enables subcutaneous delivery of partner medicines through ENHANZE technology.
$112.94
vs last close−2.19 (−1.90%)
Something off on this page? Send us feedback.
Next report
Nov 2, 26
in 40 days
EPS estimate
$2.25
Revenue estimate
$482.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.26$1.11$1.54$1.72−$0.24$1.60$2.28Pending
Estimate$1.17$0.95$1.23$1.63$2.15$1.55$1.79$2.25
Surprise+7.7%+16.8%+25.2%+5.5%−111.2%+3.2%+27.4%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$298.0M$264.9M$325.7M$354.3M$451.8M$376.7M$481.0MPending
Estimate$285.7M$281.0M$330.8M$446.5M$435.7M$358.6M$402.3M$482.3M
Surprise+4.3%−5.7%−1.5%−20.7%+3.7%+5.0%+19.6%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $2.73 | — | — |
| Sep 2027 | $2.63 | — | — |
| Jun 2027 | $2.48 | — | — |
| Mar 2027 | $2.22 | — | — |
| Dec 2026 | $2.56 | — | — |
| Nov 2026 | $2.25 | — | — |
| Aug 2026 | $1.79 | $2.28 | +27.4% |
| May 2026 | $1.55 | $1.60 | +3.2% |
| Feb 2026 | $2.15 | −$0.24 | −111.2% |
| Nov 2025 | $1.63 | $1.72 | +5.5% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $2.73 | — | — | $536.4M | — | — | — |
| Sep 2027 | $2.63 | — | — | $537.2M | — | — | — |
| Jun 2027 | $2.48 | — | — | $519.2M | — | — | — |
| Mar 2027 | $2.22 | — | — | $461.9M | — | — | — |
| Dec 2026 | $2.56 | — | — | $533.3M | — | — | — |
| Nov 2, 2026 | $2.25 | — | — | $482.3M | — | — | — |
| Aug 6, 2026 | $1.79 | $2.28 | +27.4% | $402.3M | $481.0M | +19.6% | +20.2% |
| May 11, 2026 | $1.55 | $1.60 | +3.2% | $358.6M | $376.7M | +5.0% | +6.8% |
| Feb 17, 2026 | $2.15 | −$0.24 | −111.2% | $435.7M | $451.8M | +3.7% | −9.0% |
| Nov 3, 2025 | $1.63 | $1.72 | +5.5% | $446.5M | $354.3M | −20.7% | +2.8% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 18, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 21, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 10, 2021 | |||||||
| Feb 23, 2021 | |||||||
| Nov 2, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 24, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 21, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 10, 2018 | |||||||
| Feb 20, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |